Bioethics (BOTH) Stock Forecast & Price Target
BOTH Analyst Ratings
There are no analyst ratings in the last 3 months.
BOTH Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts​
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Tristan Gerra | Robert W. Baird | ― | buy | ― | Reiterated | 05/04/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Tristan GerraRobert W. Baird | BuyReiterated | 05/04/26 | ― |
Best Analysts Covering Bioethics
Copying Tristan Gerra's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
Copying Tristan Gerra's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
Copying Tristan Gerra's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
BOTH Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 0 | 0 | 0 | 0 |
In the current month, BOTH has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BOTH average Analyst price target in the past 3 months is ―.
BOTH Financial Forecast
BOTH Earnings Forecast
Next quarter’s earnings estimate for BOTH is -$0.13 with a range of ― to ―. The previous quarter’s EPS was $0.00. BOTH beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 81.82% of the time in the same period. In the last calendar year BOTH has Performed in-line its overall industry.
